To view the PDF file, sign up for a MySharenet subscription.

DIS-CHEM PHARMACIES LIMITED - Directors' dealings in securities

Release Date: 23/11/2016 17:50
Code(s): DCP     PDF:  
Wrap Text
Directors' dealings in securities

Dis-Chem Pharmacies Limited
(Previously Dis-Chem Pharmacies Proprietary Limited)
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or the “Company”)

Directors’ dealing announcement

In order to align the interests of the board of directors (“Board”) and shareholders of
Dis-Chem, the Company has invited each of the Board members to participate in the private
placement as part of the listing on the JSE Limited (“JSE”). In light thereof, the following is
hereby disclosed in compliance with section 3.63 to 3.74 of the Listings Requirements of the
JSE:

Name of director:                               LM Nestadt
Date of transaction:                            18 November 2016
Number of shares:                               2 702 703
Price per share:                                R 18.50
Total value:                                    R 50 000 005.50
Class of securities:                            Ordinary shares
Nature of transaction:                          Off market purchase of shares in terms of
                                                the Dis-Chem private placement
Nature and extent of director’s interest:       Direct beneficial

Name of director:                               Joe Mthimunye
Date of transaction:                            18 November 2016
Number of shares:                               162 162
Price per share:                                R 18.50
Total value:                                    R 2 999 997.00
Class of securities:                            Ordinary shares
Nature of transaction:                          Off market purchase of shares in terms of
                                                the Dis-Chem private placement
Nature and extent of director’s interest:       Direct beneficial

Name of director:                               Anuschka Coovadia
Date of transaction:                            18 November 2016
Number of shares:                               162 162
Price per share:                                R 18.50
Total value:                                    R 2 999 997.00
Class of securities:                            Ordinary shares
Nature of transaction:                          Off market purchase of shares in terms of
                                                the Dis-Chem private placement
Nature and extent of director’s interest:       Direct beneficial

Name of director:                               Mark Bowman
Date of transaction:                            18 November 2016
Number of shares:                               81 081
Price per share:                                R 18.50
Total value:                                    R 1 499 998.50
Class of securities:                            Ordinary shares
Nature of transaction:                          Off market purchase of shares in terms of
                                                the Dis-Chem private placement
Nature and extent of director’s interest:       Direct beneficial
Clearance to deal in these shares was obtained.

Midrand
23 November 2016

Sponsor
The Standard Bank of South Africa Limited

Date: 23/11/2016 05:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story